Research data suggests life sciences companies will face many industry changes during the next ten years. Some of these changes include globalization increases, widespread restructuring, big layoffs, outsourcing of jobs and services, rise of emerging markets, growth of the generic drug market, and more. According to a recent Deloitte survey of senior executives in the life sciences industry, bio and pharma firms expect that by 2015, more than 50% of their revenues will come from products and services that are not offered today. In light of these industry changes and this recent survey statistic, companies need successful strategies to stay profitable, maintain a strong pipeline of products and services, and maintain a high reputation. Is your company poised to be successful? Do you have the right resources in place to deliver innovative products and services yet to be determined? Do you know what products and services your company needs to be creating? This Executive Summit will present case studies of business models that support successful strategies and innovations. Examples from inside and outside the life sciences industry will be discussed. The Summit will also be co-located with Molecular Medicine Tri-Conference.

Case studies of business models will be covered that show:

• New product and service development

• Expanded R&D investment in emerging markets

• Cross-border negotiations

• Improvement of R&D efficiency

• Modified sales and marketing approaches that are customer-centric

• Recruitment, retention and skill development of top talent

• Successful outsourcing arrangements

• Improvement of infrastructure and technology

• New partner, alliance and collaboration models

• Novel approaches toward product commercialization

• Diversification of product and service portfolio

• Accelerating the discovery-to-market timeline

• Alternative financing strategies

Who should attend: Attendance to the Executive Summit will be limited to qualified attendees - directors and higher from pharmaceutical and biotechnology organizations; senior faculty at research universities, institutes and government agencies; and Summit sponsors.

If you have a new way of doing business and would like to speak about it, we would love to hear from you! CHI invites you to submit a speaking proposal for consideration by our Advisory Committee.

Click here to submit a speaking proposal.

The deadline for submission is August 8, 2008.

Please note that due to limited speaking slots, preference will be given to pharmaceutical and biotech companies. Additionally, as per the program policy, a select number of vendors and consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions or suggestions about the meeting, please contact:
Cindy Crowninshield
Cambridge Healthtech Institute
Tel: 781-354-0120
email: ccrowninshield@healthtech.com

For sponsorship and exhibit sales information, please contact:
Arnold Wolfson
Cambridge Healthtech Institute
Phone: 781-972-5431
Email: awolfson@healthtech.com